[1] World Bank. World Bank Open Data. World Bank Open Data n.d. https://data.worldbank.org/country/ZG (accessed April 15, 2023).
[2] El Bcheraoui C, Mimche H, Miangotar Y, Krish VS, Ziegeweid F, Krohn KJ, et al. Burden of disease in francophone Africa, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Glob Health 2020;8:e341–51. https://doi.org/10.1016/S2214-109X(20)30024-3.
[3] World Health Organization. Intersectoral Global Action Plan on epilepsy and other neurological disorders 2022 – 2031 n.d. https://www.who.int/publications/m/item/intersectoral-global-action-plan-on-eepilepsy-and-other-neurological-disorders-2022-2031 (accessed April 15, 2023).
[4] Maestre G, Carrillo M, Kalaria R, Acosta D, Adams L, Adoukonou T, et al. The Nairobi Declaration—Reducing the burden of dementia in low‐ and middle‐income countries (LMICs): Declaration of the 2022 Symposium on Dementia and Brain Aging in LMICs. Alzheimers Dement 2023;19:1105–8. https://doi.org/10.1002/alz.13025.
[5] A blueprint for dementia research n.d. https://apps.who.int/iris/rest/bitstreams/1471590/retrieve (accessed March 12, 2023).
[6] the EPIDEMCA group, Guerchet M, Mbelesso P, Ndamba-Bandzouzi B, Pilleron S, Desormais I, et al. Epidemiology of dementia in Central Africa (EPIDEMCA): protocol for a multicentre population-based study in rural and urban areas of the Central African Republic and the Republic of Congo. SpringerPlus 2014;3:1044. https://doi.org/10.1186/2193-1801-3-338.
[7] Djimdé SO, Coulibaly T, Landoure G, Sissoko AS, Coulibaly T, Bagayoko H, et al. Profil Epidémiologique et Clinique des Démences Vasculaires au Service de Neurologie du CHU-Point « G » 2022;23.
[8] Léonard KK, Mamonma M, Ismaïla D, Samuel YN, Yves BN, Tania EAN, et al. EPIDEMIOLOGICAL, CLINICAL AND ETIOLOGICAL PROFILE OF NEUROCOGNITIVE DISORDERS IN MEMORY CONSULTATION IN ABIDJAN. Afr J Neurol Sci 2022;41.
[9] Akinyemi RO, Yaria J, Ojagbemi A, Guerchet M, Okubadejo N, Njamnshi AK, et al. Dementia in Africa: Current evidence, knowledge gaps, and future directions. Alzheimers Dement J Alzheimers Assoc 2022;18:790–809. https://doi.org/10.1002/alz.12432.
[10] Guerchet M, Houinato D, Paraiso MN, von Ahsen N, Nubukpo P, Otto M, et al. Cognitive Impairment and Dementia in Elderly People Living in Rural Benin, West Africa. Dement Geriatr Cogn Disord 2009;27:34–41. https://doi.org/10.1159/000188661.
[11] Mbelesso P, Tabo A, Guerchet M, Mouanga AM, Bandzouzi B, Houinato D, et al. Épidémiologie des démences chez les personnes âgées dans le troisième arrondissement de la ville de Bangui (République Centrafricaine). Bull Société Pathol Exot 2012;105:388–95. https://doi.org/10.1007/s13149-012-0247-8.
[12] Njamnshi AK, Chokote E-S, Ngarka L, Nfor LN, Tabah EN, Atchou JGB, et al. Epilepsy-associated neurocognitive disorders (EAND) in an onchocerciasis-endemic rural community in Cameroon: A population-based case–control study. Epilepsy Behav 2020;112:107437. https://doi.org/10.1016/j.yebeh.2020.107437.
[13] Adoukonou T, Yoro-Zohoun I, Gnonlonfoun DD, Amoussou P, Takpara C, Agbetou M, et al. Prevalence of Dementia among Well-Educated Old-Age Pensioners in Parakou (Benin) in 2014. Dement Geriatr Cogn Disord 2020;49:210–8. https://doi.org/10.1159/000508623.
[14] Toure K, Coume M, Ndiaye M, Zunzunegui MV, Bacher Y, Diop AG, et al. Risk Factors for Dementia in a Senegalese Elderly Population Aged 65 Years and Over. Dement Geriatr Cogn Disord Extra 2012;2:160–8. https://doi.org/10.1159/000332022.
[15] Callixte K-T, Clet TB, Jacques D, Faustin Y, François DJ, Maturin T-T. The pattern of neurological diseases in elderly people in outpatient consultations in Sub-Saharan Africa. BMC Res Notes 2015;8:159. https://doi.org/10.1186/s13104-015-1116-x.
[16] Njamnshi AK, Mengnjo MK, Mbong EN, Chokote ET, Nfor LN, Ngarka L, et al. Sleep patterns and risk of cognitive impairment in hypertensive patients in Yaounde, Cameroon, Sub-Saharan Africa. J Neurol Sci 2015;357:e97. https://doi.org/10.1016/j.jns.2015.08.320.
[17] Wanvoegbe FA, Gnonlonfoun DD, Agbodande KA, Fandi AA-G, Gnanguenon MB, Azon-Kouanou A, et al. Dementia and Diabetes Mellitus in Porto-Novo: Frequency and Determining Factors. Open J Intern Med 2021;11:246–57. https://doi.org/10.4236/ojim.2021.114021.
[18] Abba ZI, Mboue-Djieka Y, Mapoure YN, Nkouonlack C, Luma HN, Choukem S-P. Prevalence and risk factors of cognitive dysfunction in patients with type 2 diabetes mellitus receiving care in a reference hospital in Cameroon: a cross-sectional study. Int J Diabetes Dev Ctries 2018;38:158–64. https://doi.org/10.1007/s13410-017-0565-2.
[19] Gnonlonfoun DD, Ossou-Nguiet PM, Diallo LL, Adjien C, Avlessi I, Goudjinou G, et al. Post-Stroke Cognitive Disorders and Associated Factors in French Speaking West Africa, Benin Case. Neurosci Med 2014;05:32–41. https://doi.org/10.4236/nm.2014.51006.
[20] Onadja Y, Atchessi N, Soura BA, Rossier C, Zunzunegui M-V. Gender differences in cognitive impairment and mobility disability in old age: A cross-sectional study in Ouagadougou, Burkina Faso. Arch Gerontol Geriatr 2013;57:311–8. https://doi.org/10.1016/j.archger.2013.06.007.
[21] Guerchet MM, Mayston R, Lloyd-Sherlock P, Prince MJ, Aboderin I, Akinyemi R et al. Dementia in sub-Saharan Africa: Challenges and opportunities n.d. https://www.alzint.org/resource/dementia-in-sub-saharan-africa/ (accessed April 17, 2023).
[22] United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects 2022: Summary of Results 2022.
[23] Aboderin IAG, He W, Adjaye-Gbewonyo D. Africa Aging 2020. US Census; 2020.
[24] Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 2022;7:e105–25. https://doi.org/10.1016/S2468-2667(21)00249-8.
[25] Guerchet M, Prince M, Prina M. The Global Impact of Dementia 2013-2050: Policy brief 2013.
[26] Li X, Feng X, Sun X, Hou N, Han F, Liu Y. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2019. Front Aging Neurosci 2022;14:937486. https://doi.org/10.3389/fnagi.2022.937486.
[27] Global Dementia Cases Forecasted to Triple by 2050 | AAIC 2021. AAIC n.d. //aaic.alz.org/releases_2021/global-prevalence.asp (accessed March 12, 2023).
[28] GBD 2019 Collaborators. Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019. Alzheimers Dement N Y N 2021;7:e12200. https://doi.org/10.1002/trc2.12200.
[29] Prince M, Ali G-C, Guerchet M, Prina AM, Albanese E, Wu Y-T. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther 2016;8:23. https://doi.org/10.1186/s13195-016-0188-8.
[30] Cantarero-Prieto D, Leon PL, Blazquez-Fernandez C, Juan PS, Cobo CS. The economic cost of dementia: A systematic review. Dementia 2020;19:2637–57. https://doi.org/10.1177/1471301219837776.
[31] Velandia PP, Miller-Petrie MK, Chen C, Chakrabarti S, Chapin A, Hay S, et al. Global and regional spending on dementia care from 2000-2019 and expected future health spending scenarios from 2020-2050: An economic modelling exercise. EClinicalMedicine 2022;45:101337. https://doi.org/10.1016/j.eclinm.2022.101337.
[32] George-Carey R, Adeloye D, Chan KY, Paul A, Kolčić I, Campbell H, et al. An estimate of the prevalence of dementia in Africa: A systematic analysis. J Glob Health 2012;2:020401. https://doi.org/10.7189/jogh.02.020401.
[33] Wimo A, Aboderin I, Guerchet M, Prince M, Amoakoh-Coleman M, Ezeah P, et al. Dementia in sub-Saharan Africa: Challenges and opportunities 2017.
[34] Olayinka OO, Mbuyi NN. Epidemiology of Dementia among the Elderly in Sub-Saharan Africa. Int J Alzheimer’s Dis 2014;2014:e195750. https://doi.org/10.1155/2014/195750.
[35] Brooke J, Ojo O. Contemporary views on dementia as witchcraft in sub-Saharan Africa: A systematic literature review. J Clin Nurs 2020;29:20–30. https://doi.org/10.1111/jocn.15066.
[36] Guerchet M, Houinato D, Mouanga AM, M’belesso P, Nubukpo P, Clément J-P, et al. O3-01-03: Risk factors for dementia in elderly living in three French-speaking African countries. Alzheimers Dement 2010;6:S124–S124. https://doi.org/10.1016/j.jalz.2010.05.391.
[37] Ojagbemi A, Okekunle AP, Babatunde O. Dominant and Modifiable Risk Factors for Dementia in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Front Neurol 2021;12.
[38] Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, et al. Perspectives on ethnic and racial disparities in Alzheimer’s disease and related dementias: Update and areas of immediate need. Alzheimers Dement J Alzheimers Assoc 2019;15:292–312. https://doi.org/10.1016/j.jalz.2018.09.009.
[39] Farina N, Jacobs R, Sani TP, Schneider M, Theresia I, Turana Y, et al. Description of the cross-cultural process adopted in the STRiDE (STrengthening Responses to dementia in DEveloping countries) program: A methodological overview. Alzheimers Dement Amst Neth 2022;14:e12293. https://doi.org/10.1002/dad2.12293.
[40] James T, Mukadam N, Sommerlad A, Guerra Ceballos S, Livingston G. Culturally tailored therapeutic interventions for people affected by dementia: a systematic review and new conceptual model. Lancet Healthy Longev 2021;2:e171–9. https://doi.org/10.1016/S2666-7568(21)00001-5.
[41] Akinyemi RO, Yaria J, Ojagbemi A, Guerchet M, Okubadejo N, Njamnshi AK, et al. Dementia in Africa: Current evidence, knowledge gaps, and future directions. Alzheimers Dement 2022;18:790–809. https://doi.org/10.1002/alz.12432.
[42] Napon C, Traore S, Niakara A, Ouango G, Ouango A, Kabore J. Les démences en afrique subsaharienne : aspects cliniques et étiologiques en milieu hospitalier à ouagadougou (burkina faso). Afr J Neurol Sci 2010;28. https://doi.org/10.4314/ajns.v28i1.55132.
[43] GBD 2019 Collaborators, Nichols E, Abd‐Allah F, Abdoli A, Abosetugn AE, Abrha WA, et al. Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019. Alzheimers Dement Transl Res Clin Interv 2021;7. https://doi.org/10.1002/trc2.12200.
[44] Samba H, Guerchet M, Ndamba-Bandzouzi B, Mbelesso P, Lacroix P, Dartigues J-F, et al. Dementia-associated mortality and its predictors among older adults in sub-Saharan Africa: results from a 2-year follow-up in Congo (the EPIDEMCA-FU study). Age Ageing 2016;45:680–6. https://doi.org/10.1093/ageing/afw097.
[45] Ojagbemi A, Okekunle AP, Babatunde O. Dominant and Modifiable Risk Factors for Dementia in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Front Neurol 2021;12:627761. https://doi.org/10.3389/fneur.2021.627761.
[46] Atashili J, Gaynes BN, Pence BW, Tayong G, Kats D, O’donnell JK, et al. Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study. BMC Neurol 2013;13:86. https://doi.org/10.1186/1471-2377-13-86.
[47] Kanmogne GD, Kuate CT, Cysique LA, Fonsah JY, Eta S, Doh R, et al. HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol 2010;10:60. https://doi.org/10.1186/1471-2377-10-60.
[48] Njamnshi AK, Djientcheu V de P, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WF. The International HIV Dementia Scale Is a Useful Screening Tool for HIV-Associated Dementia/Cognitive Impairment in HIV-Infected Adults in Yaoundé-Cameroon. JAIDS J Acquir Immune Defic Syndr 2008;49:393–7. https://doi.org/10.1097/QAI.0b013e318183a9df.
[49] Njamnshi A, Agbor CA, Mah E, Ngarka L, Angwafor S, Njamnshi WY, et al. Neurocognitive impairment and epilepsy in school-aged children after severe malaria in a malaria endemic area. J Neurol Sci 2021;429:118933. https://doi.org/10.1016/j.jns.2021.118933.
[50] For the EPIDEMCA Group, Pilleron S, Desport J-C, Jésus P, Mbelesso P, Ndamba-Bandzouzi B, et al. Diet, alcohol consumption and cognitive disorders in Central Africa: A study from the EPIDEMCA program. J Nutr Health Aging 2015;19:657–67. https://doi.org/10.1007/s12603-015-0487-y.
[51] de Rouvray C, Jésus P, Guerchet M, Fayemendy P, Mouanga AM, Mbelesso P, et al. The nutritional status of older people with and without dementia living in an urban setting in Central Africa: The EDAC study. J Nutr Health Aging 2014;18:868–75. https://doi.org/10.1007/s12603-014-0483-7.
[52] Pilleron S, Jésus P, Desport J-C, Mbelesso P, Ndamba-Bandzouzi B, Clément J-P, et al. Association between mild cognitive impairment and dementia and undernutrition among elderly people in Central Africa: some results from the EPIDEMCA (Epidemiology of Dementia in Central Africa) programme. Br J Nutr 2015;114:306–15. https://doi.org/10.1017/S0007114515001749.
[53] Yoro-Zohoun I, Houinato D, Nubukpo P, Mbelesso P, Ndamba-Bandzouzi B, Lambert J-C, et al. Apolipoprotein E ϵ4 allele and neuropsychiatric symptoms among older adults in Central Africa (EPIDEMCA study). Int Psychogeriatr 2021;33:295–306. https://doi.org/10.1017/S1041610220003993.
[54] Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina AM, Winblad B, et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement J Alzheimers Assoc 2017;13:1–7. https://doi.org/10.1016/j.jalz.2016.07.150.
[55] Jia J, Wei C, Chen S, Li F, Tang Y, Qin W, et al. The cost of Alzheimer’s disease in China and re-estimation of costs worldwide. Alzheimers Dement J Alzheimers Assoc 2018;14:483–91. https://doi.org/10.1016/j.jalz.2017.12.006.
[56] Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q. The Humanistic and Economic Burden of Alzheimer’s Disease. Neurol Ther 2022;11:525–51. https://doi.org/10.1007/s40120-022-00335-x.
[57] de la Perrelle L, Radisic G, Cations M, Kaambwa B, Barbery G, Laver K. Costs and economic evaluations of Quality Improvement Collaboratives in healthcare: a systematic review. BMC Health Serv Res 2020;20:155. https://doi.org/10.1186/s12913-020-4981-5.
[58] Landeiro F, Morton J, Gustavsson A, Potashman M, Lecomte P, Belger M, et al. Health economic modeling for Alzheimer’s disease: Expert perspectives. Alzheimers Dement N Y N 2022;8:e12360. https://doi.org/10.1002/trc2.12360.
[59] Ruiz-Adame M. A Systematic Review of the Indirect and Social Costs in Early and Young Onset Dementias. J Alzheimers Dis JAD 2022;85:21–9. https://doi.org/10.3233/JAD-215204.
[60] Paraïso MN, Guerchet M, Saizonou J, Cowppli-Bony P, Mouanga AM, Nubukpo P, et al. Prevalence of dementia among elderly people living in Cotonou, an urban area of Benin (West Africa). Neuroepidemiology 2011;36:245–51. https://doi.org/10.1159/000328255.
[61] Gnonlonfoun DD, Adjien C, Ossou-Nguiet PM, Diallo LL, Houannou O, Acakpo J, et al. Prevalence of Dementia and Its Associated Factors in Cotonou Teaching Hospital, Benin. Adv Alzheimers Dis 2014;03:94–106. https://doi.org/10.4236/aad.2014.32010.
[62] Dabilgou AA, Alassane Dravé, Julie M, Kyelem A, Kouka Abel Nana, Napon C, et al. Cognitive Disorders in Patients with Epilepsy Attending at Neurology Outpatient Clinics. A Multicenter Prospective Cross-Sectional Study from Burkina Faso- International Journal of Neurological Disorders SCIRES Literature -Volume 3 Issue 1 -www.scireslit.com International Journal of Neurological Disorders 2019. https://doi.org/10.13140/RG.2.2.22239.20646.
[63] Ouango JG, Goumbri P, Karfo K, Nana B, Ouédraogo A. Caractéristiques sociodémographiques, cliniques et thérapeutiques de la démence au Burkina Faso. NPG Neurol - Psychiatr - Gériatrie 2014;14:163–8. https://doi.org/10.1016/j.npg.2013.11.003.
[64] Ngarka L, Mundih N, Njamnshi WY, Nfor L, Mengnjo M, Angwafor S, et al. Epidemiological, clinical and comparative study of neurocognitive and sleep disorders in patients with onchocerciasis-associated epilepsy in the Monatélé Health District, Center Region of Cameroon. J Neurol Sci 2021;429:119159. https://doi.org/10.1016/j.jns.2021.119159.
[65] Njamnshi WY, Ruffieux N, Ngarka L, Chabwine J, Straccia C, Fonsah J, et al. Cognitive testing in indigenous populations in Cameroon – Challenges and opportunities in the Baka Pygmy and Mbororo groups. J Neurol Sci 2021;429:118584. https://doi.org/10.1016/j.jns.2021.118584.
[66] Tianyi FL, Agbor VN, Njamnshi AK, Atashili J. Factors Associated with the Prevalence of Cognitive Impairment in a Rural Elderly Cameroonian Population: A Community-Based Study in Sub-Saharan Africa. Dement Geriatr Cogn Disord 2019;47:104–13. https://doi.org/10.1159/000496825.
[67] Ruffieux N, Njamnshi AK, Wonkam A, Hauert C-A, Chanal J, Verdon V, et al. Association between biological markers of sickle cell disease and cognitive functioning amongst Cameroonian children. Child Neuropsychol 2013;19:143–60. https://doi.org/10.1080/09297049.2011.640932.
[68] Atashili J, Gaynes BN, Pence BW, Tayong G, Kats D, O’donnell JK, et al. Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study. BMC Neurol 2013;13:86. https://doi.org/10.1186/1471-2377-13-86.
[69] Mapoure NY, Mbessa Essoga MM, Ba H, Nkouonlack C, Gams MD, Luma NH. Post-stroke cognitive impairment in Douala (Cameroon). Afr J Neurol Sci 2017;36:43–52.
[70] Essomba MJN, Atsa D, Noah DZ, Zingui-Ottou M, Paula G, Nkeck JR, et al. Geriatric syndromes in an urban elderly population in Cameroon: a focus on disability, sarcopenia and cognitive impairment. Pan Afr Med J 2020;37. https://doi.org/10.11604/pamj.2020.37.229.26634.
[71] Kengne AP, Dzudie A, Dongmo L. Epidemiological features of degenerative brain diseases as they occurred in Yaounde referral hospitals over a 9-year period. Neuroepidemiology 2006;27:208–11. https://doi.org/10.1159/000096609.
[72] Morin A, Guillaume M, Ngarka L, Tatah GY, Siewe Fodjo JN, Wyart G, et al. Epilepsy in the Sanaga‐Mbam valley, an onchocerciasis‐endemic region in Cameroon: electroclinical and neuropsychological findings. Epilepsia Open 2021:epi4.12510. https://doi.org/10.1002/epi4.12510.
[73] Siewe Fodjo JN, Njamnshi WY, Ngarka L, Nfor LN, Ayuk C, Mundih NN, et al. Association Between Ov16 Seropositivity and Neurocognitive Performance Among Children in Rural Cameroon: a Pilot Study. J Pediatr Neuropsychol 2021;7:192–202. https://doi.org/10.1007/s40817-021-00111-z.
[74] Mbelesso P, Tabo A, Guerchet M, Mouanga AM, Bandzouzi B, Houinato D, et al. Épidémiologie des démences chez les personnes âgées dans le troisième arrondissement de la ville de Bangui (République Centrafricaine). Bull Société Pathol Exot 2012;105:388–95. https://doi.org/10.1007/s13149-012-0247-8.
[75] Guerchet M, M’belesso P, Mouanga AM, Bandzouzi B, Tabo A, Houinato DS, et al. Prevalence of Dementia in Elderly Living in Two Cities of Central Africa: The EDAC Survey. Dement Geriatr Cogn Disord 2010;30:261–8. https://doi.org/10.1159/000320247.
[76] Guerchet M, Mbelesso P, Mouanga AM, Tabo A, Bandzouzi B, Clément J, et al. Association Between a Low Ankle–Brachial Index and Dementia in a General Elderly Population in Central Africa (Epidemiology of Dementia in Central Africa Study). J Am Geriatr Soc 2013;61:1135–40. https://doi.org/10.1111/jgs.12310.
[77] Ossou-Nguiet PM, Doungou ND, Mpandzou GA, Ngouma YAPE, Obondzo-Aloba K, Banzouzi LF, et al. Troubles cognitifs et diabete de type 2 au Congo. Afr J Neurol Sci 2019;38:78–90. https://doi.org/10.4314/ajns.v38i1.
[78] Ikanga J, Reyes A, Kaba D, Akilimali P, Mampunza S, Epenge E, et al. Prevalence of suspected dementia in a sample of adults living in Kinshasa-Democratic Republic of the Congo. Alzheimers Dement J Alzheimers Assoc 2023. https://doi.org/10.1002/alz.13003.
[79] Kouassi KL, Ouattara DM, Diakite I, Yeo S, Sonan DT, Boa YF. Démences observées en unité de consultation mémoire à Abidjan en côte d’Ivoire. Rev Int Sc Med 2017;19:369–74.
[80] Guinto CO, Coulibaly T, Berthé S, Traoré S, Coulibaly T, Sissoko A, et al. Epidemiological and clinical aspects of HIV associated dementia at the University Hospital of Point G 2017.
[81] Andia A, Harouna G, Brah S, Makhtar B, Coume M. Aspects cliniques, paracliniques et thérapeutiques des troubles neurocognitifs en gériatrie à l’Hôpital Général de Référence de Niamey (Niger). Rev Afr Médecine Interne 2022;9:52–9.
[82] Coumé M, Touré K, Thiam HM, Moreira TD, Ndiaye MM. Facteurs de risque de déficit cognitif dans une population de patients âgés sénégalais du Centre médicosocial de l’Institution de prévoyance retraite du Sénégal, Dakar-Sénégal. Cah Année Gérontologique 2012;1:21–8. https://doi.org/10.1007/s12612-012-0254-1.
[83] Toure K, Coumé M, Ndiaye/Ndongo ND, Basse A, Sow A, Seck LB. DEFICIT COGNITIF DANS UNE POPULATION DE PATIENTS AGES SENEGALAIS DU CENTRE MEDICO-SOCIAL ET UNIVERSITAIRE DE L’IPRES, DAKAR-SENEGAL : PREVALENCE ET FACTEURS DE RISQUE. Rev Afr Malgache Rech Sci Santé 2013;1.
[84] Touré K, Coume M, Ndiaye ND, Thiam MH, Zunzunegui MV, Bacher Y, et al. Prévalence de la démence dans une population de personnes âgées Sénégalaises. Afr J Neurol Sci 2008;27.
[85] Touré K. Prevalence of dementia varied with age, education and social network in a Senegalese elderly population of patients utilizing the Medico-Social and University Center of IPRES, Dakar-Senegal. Int J Med Med Sci 2012;4. https://doi.org/10.5897/IJMMS12.013.
[86] Toure K, Coume M, Ndiaye M, Zunzunegui MV, Bacher Y, Diop AG, et al. Risk Factors for Dementia in a Senegalese Elderly Population Aged 65 Years and Over. Dement Geriatr Cogn Disord EXTRA 2012;2:160–8. https://doi.org/10.1159/000332022.
[87] Socarras ACR, Henriette K. Comportamiento de la cognición y comorbilidad en pacientes con infarto cerebral hospitalizados. Seychelles 2010-2011 Cognition and Comorbidity Behavior in Hospitalized Patients Suffering from Stroke. Seychelles 2010-201 2012.
[88] Kobrosly RW, Van Wijngaarden E, Galea S, Cory-Slechta DA, Love T, Hong C, et al. Socioeconomic Position and Cognitive Function in the Seychelles: A Life Course Analysis. Neuroepidemiology 2011;36:162–8. https://doi.org/10.1159/000325779.
[89] Lyngdoh T, Viswanathan B, Kobrosly R, Van Wijngaarden E, Huber B, Davidson PW, et al. Blood pressure and cognitive function: a prospective analysis among adolescents in Seychelles. J Hypertens 2013;31:1175–82. https://doi.org/10.1097/HJH.0b013e3283604176.
[90] Kombate D, Guinhouya K, Kpetekoussou A, Assogba K, Koumako V, Kevi S, et al. Demence vasculaire en milieu hospitalier au Togo. J Rech Sci L’Université Lomé 2016;18:169–73. https://doi.org/10.4314/jrsul.v18i2.
[91] Ineichen B. The epidemiology of dementia in Africa: a review. Soc Sci Med 1982 2000;50:1673–7. https://doi.org/10.1016/s0277-9536(99)00392-5.
[92] Napon C, Traore S, Niakara A, Ouango G, Ouango A, Kabore J. Les démences en afrique subsaharienne : aspects cliniques et étiologiques en milieu hospitalier à ouagadougou (burkina faso). Afr J Neurol Sci 2009;28. https://doi.org/10.4314/ajns.v28i1.55132.
[93] Massi DG, Aretoutap MA, Kenmegne C, Mapoure YN. Épidémiologie hospitalière des démences à Douala, Cameroun. Rev Neurol (Paris) 2020;176:S3. https://doi.org/10.1016/j.neurol.2020.01.056.
[94] Soria Lopez JA, González HM, Léger GC. Alzheimer’s disease. Handb Clin Neurol 2019;167:231–55. https://doi.org/10.1016/B978-0-12-804766-8.00013-3.
[95] Mast H, Tatemichi TK, Mohr JP. Chronic brain ischemia: the contributions of Otto Binswanger and Alois Alzheimer to the mechanisms of vascular dementia. J Neurol Sci 1995;132:4–10. https://doi.org/10.1016/0022-510x(95)00116-j.
[96] Hachinski VC, Bowler JV. Vascular dementia. Neurology 1993;43:2159–60; author reply 2160-2161. https://doi.org/10.1212/wnl.43.10.2159-a.
[97] Iadecola C, Duering M, Hachinski MD V, Joutel A, Pendlebury ST, Schneider JA, et al. Vascular Cognitive Impairment and Dementia. J Am Coll Cardiol 2019;73:3326–44. https://doi.org/10.1016/j.jacc.2019.04.034.
[98] Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, et al. Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement J Alzheimers Assoc 2018;14:280–92. https://doi.org/10.1016/j.jalz.2017.09.007.
[99] Looi JC, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 1999;53:670–8. https://doi.org/10.1212/wnl.53.4.670.
[100] Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007;69:1789–99. https://doi.org/10.1212/01.WNL.0000287431.88658.8b.
[101] Kanmogne GD, Kuate CT, Cysique LA, Fonsah JY, Eta S, Doh R, et al. HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol 2010;10:60. https://doi.org/10.1186/1471-2377-10-60.
[102] Kanmogne GD, Fonsah JY, Umlauf A, Moul J, Doh RF, Kengne AM, et al. Attention/working memory, learning and memory in adult Cameroonians: Normative data, effects of HIV infection and viral genotype. J Int Neuropsychol Soc JINS 2020;26:607–23. https://doi.org/10.1017/S1355617720000120.
[103] Njamnshi AK, Zoung-KanyiBissek AC, Ongolo-Zogo P, Tabah EN, Lekoubou AZ, Yepnjio FN, et al. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: The case of Yaoundé-Cameroon. J Neurol Sci 2009;285:149–53. https://doi.org/10.1016/j.jns.2009.06.043.
[104] Chávez-Fumagalli MA, Shrivastava P, Aguilar-Pineda JA, Nieto-Montesinos R, Del-Carpio GD, Peralta-Mestas A, et al. Diagnosis of Alzheimer’s Disease in Developed and Developing Countries: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. J Alzheimers Dis Rep 2021;5:15–30. https://doi.org/10.3233/ADR-200263.
[105] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). American Psychiatric Pub; 2013.
[106] Hugo J, Ganguli M. Dementia and Cognitive Impairment: Epidemiology, Diagnosis, and Treatment. Clin Geriatr Med 2014;30:421–42. https://doi.org/10.1016/j.cger.2014.04.001.
[107] Akinyemi RO, Yaria J, Ojagbemi A, Guerchet M, Okubadejo N, Njamnshi AK, et al. Dementia in Africa: Current evidence, knowledge gaps, and future directions. Alzheimers Dement J Alzheimers Assoc 2022;18:790–809. https://doi.org/10.1002/alz.12432.
[108] Adoukonou T, Yoro-Zohoun I, Gnonlonfoun DD, Amoussou P, Takpara C, Agbetou M, et al. Prevalence of Dementia among Well-Educated Old-Age Pensioners in Parakou (Benin) in 2014. Dement Geriatr Cogn Disord 2020;49:210–8. https://doi.org/10.1159/000508623.
[109] Guerchet M, Houinato D, Paraiso MN, von Ahsen N, Nubukpo P, Otto M, et al. Cognitive impairment and dementia in elderly people living in rural Benin, west Africa. Dement Geriatr Cogn Disord 2009;27:34–41. https://doi.org/10.1159/000188661.
[110] Pilleron S, Desport J-C, Jésus P, Mbelesso P, Ndamba-Bandzouzi B, Dartigues J-F, et al. Diet, Alcohol Consumption and Cognitive Disorders in Central Africa: A Study from the EPIDEMCA Program. J Nutr Health Aging 2015;19:657–67. https://doi.org/10.1007/s12603-015-0487-y.
[111] Guerchet M, M’belesso P, Mouanga AM, Bandzouzi B, Tabo A, Houinato DS, et al. Prevalence of dementia in elderly living in two cities of Central Africa: the EDAC survey. Dement Geriatr Cogn Disord 2010;30:261–8. https://doi.org/10.1159/000320247.
[112] Mbelesso P, Tabo A, Guerchet M, Mouanga AM, Bandzouzi B, Houinato D, et al. [Epidemiology of dementia in elderly living in the 3rd borough of Bangui (Central African Republic)]. Bull Soc Pathol Exot 1990 2012;105:388–95. https://doi.org/10.1007/s13149-012-0247-8.
[113] De Rouvray C, Jésus P, Guerchet M, Fayemendy P, Mouanga AM, Mbelesso P, et al. The nutritional status of older people with and without dementia living in an urban setting in Central Africa: the EDAC study. J Nutr Health Aging 2014;18:868–75. https://doi.org/10.1007/s12603-014-0483-7.
[114] Kanmogne GD, Kuate CT, Cysique LA, Fonsah JY, Eta S, Doh R, et al. HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol 2010;10:60. https://doi.org/10.1186/1471-2377-10-60.
[115] Kanmogne GD, Fonsah JY, Umlauf A, Moul J, Doh RF, Kengne AM, et al. Attention/Working Memory, Learning and Memory in Adult Cameroonians: Normative Data, Effects of HIV Infection and Viral Genotype. J Int Neuropsychol Soc JINS 2020;26:607–23. https://doi.org/10.1017/S1355617720000120.
[116] Tianyi FL, Agbor VN, Njamnshi AK, Atashili J. Factors Associated with the Prevalence of Cognitive Impairment in a Rural Elderly Cameroonian Population: A Community-Based Study in Sub-Saharan Africa. Dement Geriatr Cogn Disord 2019;47:104–13. https://doi.org/10.1159/000496825.
[117] Njamnshi AK, Chokote E-S, Ngarka L, Nfor LN, Tabah EN, Atchou JGB, et al. Epilepsy-associated neurocognitive disorders (EAND) in an onchocerciasis-endemic rural community in Cameroon: A population-based case-control study. Epilepsy Behav EB 2020;112:107437. https://doi.org/10.1016/j.yebeh.2020.107437.
[118] Njamnshi AK, Djientcheu V de P, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WE. The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon. J Acquir Immune Defic Syndr 1999 2008;49:393–7.
[119] Atashili J, Gaynes BN, Pence BW, Tayong G, Kats D, O’donnell JK, et al. Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study. BMC Neurol 2013;13:86. https://doi.org/10.1186/1471-2377-13-86.
[120] Njamnshi AK, Bissek ACZ-K, Ongolo-Zogo P, Tabah EN, Lekoubou AZ, Yepnjio FN, et al. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon. J Neurol Sci 2009;285:149–53. https://doi.org/10.1016/j.jns.2009.06.043.
[121] Ruffieux N, Njamnshi AK, Mayer E, Sztajzel R, Eta SC, Doh RF, et al. Neuropsychology in Cameroon: first normative data for cognitive tests among school-aged children. Child Neuropsychol J Norm Abnorm Dev Child Adolesc 2010;16:1–19. https://doi.org/10.1080/09297040902802932.
[122] Kanmogne GD, Fonsah JY, Tang B, Doh RF, Kengne AM, Umlauf A, et al. Effects of HIV on executive function and verbal fluency in Cameroon. Sci Rep 2018;8:17794. https://doi.org/10.1038/s41598-018-36193-7.
[123] Palmqvist S, Tideman P, Cullen N, Zetterberg H, Blennow K, Dage JL, et al. Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures. Nat Med 2021;27:1034–42. https://doi.org/10.1038/s41591-021-01348-z.
[124] Wahlund L-O. Structural brain imaging as a diagnostic tool in dementia, why and how? SI Imaging Neurodegener 2020;306:111183. https://doi.org/10.1016/j.pscychresns.2020.111183.
[125] Powell AL, Benson DF. Brain imaging techniques in the diagnosis of dementia. Neuropsychol Rev 1990;1:3–19. https://doi.org/10.1007/BF01108856.
[126] Park M, Moon W-J. Structural MR Imaging in the Diagnosis of Alzheimer’s Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives. Korean J Radiol 2016;17:827–45. https://doi.org/10.3348/kjr.2016.17.6.827.
[127] Reitz C, Mayeux R. Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers. Alzheimer’s Dis – Amyloid Tau Beyond 2014;88:640–51. https://doi.org/10.1016/j.bcp.2013.12.024.
[128] Schwarz CG, Gunter JL, Wiste HJ, Przybelski SA, Weigand SD, Ward CP, et al. A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer’s disease severity. NeuroImage Clin 2016;11:802–12. https://doi.org/10.1016/j.nicl.2016.05.017.
[129] Pasi M, Poggesi A, Pantoni L. The use of CT in dementia. Int Psychogeriatr 2011;23:S6–12. https://doi.org/10.1017/S1041610211000950.
[130] Anhum K, Idrissa G, Olivier TBZ, Ahoubougabe B, Akpegny K, Aristide T, et al. Exploration à l’irm crânioencéphalique des troubles cognitifs en afrique sub saharienne. J Neuroradiol 2023;50:203. https://doi.org/10.1016/j.neurad.2023.01.151.
[131] JS N, M M, EN AN, OF Z, AK N, P OZ. L’IRM Cérébrale chez un Groupe de Sujets Camerounais Âgés de Plus de 60 Ans à l’Hôpital Militaire de Yaoundé: Brain MRI findings in a sample of Cameroonian aged 60 years and more at the Yaounde Military Hospital. Health Sci Dis 2021;22.
[132] Sonhaye L, Tchaou M, Amadou A, Gbande P, Akpona R, Assih K, et al. ASPECTS TOMODENSITOMETRIQUES DES DEMENCES AU TOGO. Rev Afr Malgache Rech Sci Santé 2014;1.
[133] Anazodo UC, Ng JJ, Ehiogu B, Obungoloch J, Fatade A, Mutsaerts HJMM, et al. A framework for advancing sustainable magnetic resonance imaging access in Africa. NMR Biomed 2023;36:e4846. https://doi.org/10.1002/nbm.4846.
[134] Karungi CK, Wakida EK, Rukundo GZ, Talib ZM, Haberer JE, Obua C. Lay Health Workers in Community-Based Care and Management of Dementia: A Qualitative “Pre” and “Post” Intervention Study in Southwestern Uganda. BioMed Res Int 2022;2022:9443229. https://doi.org/10.1155/2022/9443229.
[135] van Ginneken N, Chin WY, Lim YC, Ussif A, Singh R, Shahmalak U, et al. Primary-level worker interventions for the care of people living with mental disorders and distress in low- and middle-income countries. Cochrane Database Syst Rev 2021;8:CD009149. https://doi.org/10.1002/14651858.CD009149.pub3.
[136] Ogunniyi A, Hall KS, Baiyewu O, Gureje O, Unverzagt FW, Gao S, et al. Caring for individuals with dementia: the Nigerian experience. West Afr J Med 2005;24:259–62. https://doi.org/10.4314/wajm.v24i3.28211.
[137] Hindley G, Kissima J, L. Oates L, Paddick S-M, Kisoli A, Brandsma C, et al. The role of traditional and faith healers in the treatment of dementia in Tanzania and the potential for collaboration with allopathic healthcare services. Age Ageing 2017;46:130–7. https://doi.org/10.1093/ageing/afw167.
[138] Kakongi N, Rukundo GZ, Gelaye B, Wakida EK, Obua C, Okello ES. Exploring pathways to Hospital Care for Patients with Alzheimer’s disease and related dementias in rural South Western Uganda. BMC Health Serv Res 2020;20:498. https://doi.org/10.1186/s12913-020-05365-5.
[139] Breuer E, Freeman E, Alladi S, Breedt M, Govia I, López-Ortega M, et al. Active inclusion of people living with dementia in planning for dementia care and services in low- and middle-income countries. Dement Lond Engl 2022;21:380–95. https://doi.org/10.1177/14713012211041426.
[140] Mbelesso P, Faure-Delage A, Guerchet MM, Ndamba-Bandzouzi B, Mouanga AM, Tabo A, et al. Social aspects of dementia in Central Africa (EDAC survey): Les aspects sociaux de la demences en Afrique Centrale (etude EDAC). Afr J Neurol Sci 2016;35.
[141] Kehoua G. Etude qualitative des facteurs socio-économiques et familiaux du processus de stigmatisation dans la démence en Afrique Centrale. phdthesis. Université de Limoges, 2017.
[142] Faure-Delage A, Mouanga AM, M’belesso P, Tabo A, Bandzouzi B, Dubreuil C-M, et al. Socio-Cultural Perceptions and Representations of Dementia in Brazzaville, Republic of Congo: The EDAC Survey. Dement Geriatr Cogn Disord Extra 2012;2:84–96. https://doi.org/10.1159/000335626.
[143] Kehoua G, Dubreuil C-M, Ndamba-Bandzouzi B, Guerchet M, Mbelesso P, Dartigues J-F, et al. People with Dementia in Sub-Saharan Africa: From Support to Abuse by Caregivers: Results of EPIDEMCA-FU Program in Congo. Dement Geriatr Cogn Disord Extra 2019;9:163–75. https://doi.org/10.1159/000489846.
[144] Tonda J. La guérison divine en Afrique centrale: (Congo, Gabon). KARTHALA Editions; 2002.
[145] De Rouvray C, Jésus P, Guerchet M, Fayemendy P, Mouanga AM, Mbelesso P, et al. The nutritional status of older people with and without dementia living in an urban setting in Central Africa: the EDAC study. J Nutr Health Aging 2014;18:868–75. https://doi.org/10.1007/s12603-014-0483-7.
[146] Malara A, Sgrò G, Caruso C, Ceravolo F, Curinga G, Renda GF, et al. Relationship between cognitive impairment and nutritional assessment on functional status in Calabrian long-term-care. Clin Interv Aging 2014;9:105–10. https://doi.org/10.2147/CIA.S54611.
[147] Gioan P. A. Higher education in Francophone Africa: what tools can be used to support financially-sustainable policies. World Bank Group; 2008.
[148] Bouscaren N, Pilleron S, Mbelesso P, Ndamba-Bandzouzi B, Dartigues J-F, Clément J-P, et al. Prevalence of toxoplasmosis and its association with dementia in older adults in Central Africa: a result from the EPIDEMCA programme. Trop Med Int Health TM IH 2018;23:1304–13. https://doi.org/10.1111/tmi.13151.
[149] Guerchet M, Mouanga AM, M’belesso P, Tabo A, Bandzouzi B, Paraïso MN, et al. Factors associated with dementia among elderly people living in two cities in Central Africa: the EDAC multicenter study. J Alzheimers Dis JAD 2012;29:15–24. https://doi.org/10.3233/JAD-2011-111364.
[150] Wonkam-Tingang E, Schrauwen I, Esoh KK, Bharadwaj T, Nouel-Saied LM, Acharya A, et al. A novel variant in DMXL2 gene is associated with autosomal dominant non-syndromic hearing impairment (DFNA71) in a Cameroonian family. Exp Biol Med Maywood NJ 2021;246:1524–32. https://doi.org/10.1177/1535370221999746.
[151] Thiam A, Sanka M, Ndiaye Diallo R, Torres M, Mbengue B, Nunez NF, et al. Gene expression profiling in blood from cerebral malaria patients and mild malaria patients living in Senegal. BMC Med Genomics 2019;12:148. https://doi.org/10.1186/s12920-019-0599-z.
[152] Sinan KI, Chiavaroli A, Orlando G, Bene K, Zengin G, Cziáky Z, et al. Evaluation of Pharmacological and Phytochemical Profiles Piptadeniastrum africanum (Hook.f.) Brenan Stem Bark Extracts. Biomolecules 2020;10. https://doi.org/10.3390/biom10040516.
[153] Hritcu L, Noumedem JA, Cioanca O, Hancianu M, Postu P, Mihasan M. Anxiolytic and antidepressant profile of the methanolic extract of Piper nigrum fruits in beta-amyloid (1-42) rat model of Alzheimer’s disease. Behav Brain Funct BBF 2015;11:13. https://doi.org/10.1186/s12993-015-0059-7.
[154] Damo JLK, Boiangiu RS, Brinza I, Kenko Djoumessi LB, Rebe RN, Kamleu BN, et al. Neuroprotective Potential of Guiera senegalensis (Combretaceae) Leaf Hydroethanolic Extract against Cholinergic System Dysfunctions and Oxidative Stress in Scopolamine-Induced Cognitive Impairment in Zebrafish (Danio rerio). Plants Basel Switz 2022;11. https://doi.org/10.3390/plants11091149.
[155] Djeuzong E, Kandeda AK, Djiogue S, Stéphanie L, Nguedia D, Ngueguim F, et al. Antiamnesic and Neuroprotective Effects of an Aqueous Extract of Ziziphus jujuba Mill. (Rhamnaceae) on Scopolamine-Induced Cognitive Impairments in Rats. Evid Based Complement Alternat Med 2021;2021:e5577163. https://doi.org/10.1155/2021/5577163.
[156] Kouémou NE, Taiwe GS, Moto FCO, Pale S, Ngoupaye GT, Njapdounke JSK, et al. Nootropic and Neuroprotective Effects of Dichrocephala integrifolia on Scopolamine Mouse Model of Alzheimer’s Disease. Front Pharmacol 2017;8:847. https://doi.org/10.3389/fphar.2017.00847.
[157] Kemadjou Dibacto RE, Akamba Ambamba BD, Ella FA, Biyegue Nyangono CF, Kamga Nanhah JV, Fonkoua M, et al. The neuroprotective effect of Xylopia parviflora against aluminum chloride-induced neurotoxicity in rats. Heliyon 2022;8:e09896. https://doi.org/10.1016/j.heliyon.2022.e09896.
[158] Kandeda AK, Nguedia D, Ayissi ER, Kouamouo J, Dimo T. Ziziphus jujuba (Rhamnaceae) Alleviates Working Memory Impairment and Restores Neurochemical Alterations in the Prefrontal Cortex of D-Galactose-Treated Rats. Evid-Based Complement Altern Med ECAM 2021;2021:6610864. https://doi.org/10.1155/2021/6610864.
[159] Owona BA, Njayou NF, Laufer SA, Schluesener HJ, Moundipa PF. Entada africana fraction CH₂Cl₂/MEOH 5% inhibits inducible nitric oxide synthase and pro-inflammatory cytokines gene expression induced by lipopolysaccharide in microglia. BMC Complement Altern Med 2013;13:254. https://doi.org/10.1186/1472-6882-13-254.
[160] Dzoyem JP, Nkuete AHL, Ngameni B, Eloff JN. Anti-inflammatory and anticholinesterase activity of six flavonoids isolated from Polygonum and Dorstenia species. Arch Pharm Res 2017;40:1129–34. https://doi.org/10.1007/s12272-015-0612-9.
[161] Lüth H-J, Apelt J, Ihunwo AO, Arendt T, Schliebs R. Degeneration of β-amyloid-associated cholinergic structures in transgenic APPSW mice. Brain Res 2003;977:16–22. https://doi.org/10.1016/S0006-8993(03)02658-1.
[162] Ihunwo AO, Schliebs R. Cell proliferation and total granule cell number in dentate gyrus of transgenic Tg2576 mouse. Acta Neurobiol Exp (Warsz) 2010;70:362–9.
[163] Perneczky R. Dementia treatment versus prevention. Dialogues Clin Neurosci 2019;21:43–51.
[164] Hyde C, Peters J, Bond M, Rogers G, Hoyle M, Anderson R, et al. Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer’s disease: systematic review and economic model. Age Ageing 2013;42:14–20. https://doi.org/10.1093/ageing/afs165.
[165] Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, et al. Donepezil and memantine for moderate-to-severe Alzheimer’s disease. N Engl J Med 2012;366:893–903. https://doi.org/10.1056/NEJMoa1106668.
[166] Cummings JL, Morstorf T, Zhong K. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther 2014;6:37. https://doi.org/10.1186/alzrt269.
[167] Tampi RR, Forester BP, Agronin M. Aducanumab: evidence from clinical trial data and controversies. Drugs Context 2021;10:2021-7–3. https://doi.org/10.7573/dic.2021-7-3.
[168] Llibre-Guerra JJ, Heavener A, Brucki SMD, Marante JPD, Pintado-Caipa M, Chen Y, et al. A call for clinical trial globalization in Alzheimer’s disease and related dementia. Alzheimers Dement n.d.;n/a. https://doi.org/10.1002/alz.12995.
[169] Gregory J, Vengalasetti YV, Bredesen DE, Rao RV. Neuroprotective Herbs for the Management of Alzheimer’s Disease. Biomolecules 2021;11:543. https://doi.org/10.3390/biom11040543.
[170] Kandeda AK, Mabou ST, Moutchida C. An aqueous extract of Lantana camara attenuates seizures, memory impairment, and anxiety in kainate-treated mice: Evidence of GABA level, oxidative stress, immune and neuronal loss modulation. Epilepsy Behav 2022;129:108611. https://doi.org/10.1016/j.yebeh.2022.108611.
[171] Sotoing Taïwe G, Ngo Bum E, Talla E, Dawe A, Okomolo Moto FC, Temkou Ngoupaye G, et al. Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense (Hutch.) Milne-Redh (Asteraceae) in rodents. J Ethnopharmacol 2012;143:213–20. https://doi.org/10.1016/j.jep.2012.06.026.
[172] Ahidjo N, Ngarka L, Seke Etet PF, Njamnshi WY, Nfor LN, Mengnjo MK, et al. Garcinia kola improves cognitive and motor function of a rat model of acute radiation syndrome in the elevated plus maze. Brain Commun 2021;3:fcab170. https://doi.org/10.1093/braincomms/fcab170.
[173] S H, P K-C, Jn O, J Q-L. In vitro screening on β-amyloid peptide production of plants used in traditional medicine for cognitive disorders. J Ethnopharmacol 2010;131. https://doi.org/10.1016/j.jep.2010.07.044.
[174] Petrelli F, Scandella V, Montessuit S, Zamboni N, Martinou J-C, Knobloch M. Mitochondrial pyruvate metabolism regulates the activation of quiescent adult neural stem cells. Sci Adv 2023;9:eadd5220. https://doi.org/10.1126/sciadv.add5220.
[175] Weeks J. Integrative MEND Protocol for Reversing Alzheimer’s Picked Up in Aging and by George Washington University … plus more. Integr Med Clin J 2016;15:24.
[176] Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. The Lancet 2017;390:2673–734. https://doi.org/10.1016/S0140-6736(17)31363-6.
[177] Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet 2020;396:413–46. https://doi.org/10.1016/S0140-6736(20)30367-6.
[178] Kane RL, Butler M, Fink HA, Brasure M, Davila H, Desai P, et al. Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017.
[179] Mukadam N, Sommerlad A, Huntley J, Livingston G. Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data. Lancet Glob Health 2019;7:e596–603. https://doi.org/10.1016/S2214-109X(19)30074-9.
[180] Oliveira D, Ferri CP. Potential for dementia prevention in Latin America and Africa based on population-attributable fraction estimates. Lancet Glob Health 2019;7:e1324. https://doi.org/10.1016/S2214-109X(19)30324-9.
[181] Peters R, Breitner J, James S, Jicha GA, Meyer P-F, Richards M, et al. Dementia risk reduction: why haven’t the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors. Alzheimers Dement Transl Res Clin Interv 2021;7:e12202. https://doi.org/10.1002/trc2.12202.
[182] Habib AG, Yakasai AM, Owolabi LF, Ibrahim A, Habib ZG, Gudaji M, et al. Neurocognitive impairment in HIV-1-infected adults in Sub-Saharan Africa: a systematic review and meta-analysis. Int J Infect Dis 2013;17:e820–31. https://doi.org/10.1016/j.ijid.2013.06.011.
[183] Akinyemi RO, Yaria J, Ojagbemi A, Guerchet M, Okubadejo N, Njamnshi AK, et al. Dementia in Africa: Current evidence, knowledge gaps, and future directions. Alzheimers Dement 2022;18:790–809. https://doi.org/10.1002/alz.12432.
[184] Stephen R, Barbera M, Peters R, Ee N, Zheng L, Lehtisalo J, et al. Development of the First WHO Guidelines for Risk Reduction of Cognitive Decline and Dementia: Lessons Learned and Future Directions. Front Neurol 2021;12.
[185] World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines n.d.
[186] Anstey KJ, Zheng L, Peters R, Kootar S, Barbera M, Stephen R, et al. Dementia Risk Scores and Their Role in the Implementation of Risk Reduction Guidelines. Front Neurol 2022;12.
[187] Onyekwuluje CI, Willis R, Ogbueche CM. Dementia knowledge among physiotherapists in Nigeria. Dement Lond Engl 2023;22:378–89. https://doi.org/10.1177/14713012221148780.